Cargando…
High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma
Twenty six patients with pleural mesothelioma of UICC stage I–IV excluding M1 disease (46% of whom had stage I disease and 38% stage III disease) were treated intravenously with high dose MTX (3 g) and calcium folinate rescue three times at intervals of 2 weeks and three times at intervals of 3 week...
Autores principales: | Halme, M, Knuuttila, A, Vehmas, T, Tammilehto, L, Mäntylä, M, Salo, J, Mattson, K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363122/ https://www.ncbi.nlm.nih.gov/pubmed/10468296 http://dx.doi.org/10.1038/sj.bjc.6690597 |
Ejemplares similares
-
Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis
por: Björkqvist, A-M, et al.
Publicado: (1999) -
Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos
por: Magnani, C, et al.
Publicado: (2000) -
Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma
por: Kahlos, K, et al.
Publicado: (2000) -
Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009) -
Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)